The latest in digital therapeutics: 3 developments from the past day, tracked and curated by the HealthTech Cube news desk. The lead story: Phase 3 Schizophrenia Trial Results Highlight Potential of Click Therapeutics’ CT-155.
Follow the full firehose on the HTC Wire, refreshed automatically every day.
Reach the people behind these stories. HealthTech Cube demand gen programs deliver qualified healthcare technology leads from $49.50 per lead - see packages or download the 2026 media kit.